Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Endometriosis Therapies Revenue 1.4 Market Analysis by Type 1.4.1 Global Endometriosis Therapies Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Hormonal Contraceptives 1.4.3 Gonadotropin-releasingHormone(Gn-RH)Agonists 1.4.4 Progestin Therapy 1.4.5 Aromatase Inhibitors 1.5 Market by Application 1.5.1 Global Endometriosis Therapies Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Endometriosis Therapies Market Perspective (2015-2026) 2.2 Endometriosis Therapies Growth Trends by Regions 2.2.1 Endometriosis Therapies Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Endometriosis Therapies Historic Market Share by Regions (2015-2020) 2.2.3 Endometriosis Therapies Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Endometriosis Therapies Market Growth Strategy 2.3.6 Primary Interviews with Key Endometriosis Therapies Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Endometriosis Therapies Players by Market Size 3.1.1 Global Top Endometriosis Therapies Players by Revenue (2015-2020) 3.1.2 Global Endometriosis Therapies Revenue Market Share by Players (2015-2020) 3.1.3 Global Endometriosis Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Endometriosis Therapies Market Concentration Ratio 3.2.1 Global Endometriosis Therapies Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Endometriosis Therapies Revenue in 2019 3.3 Endometriosis Therapies Key Players Head office and Area Served 3.4 Key Players Endometriosis Therapies Product Solution and Service 3.5 Date of Enter into Endometriosis Therapies Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Endometriosis Therapies Historic Market Size by Type (2015-2020) 4.2 Global Endometriosis Therapies Forecasted Market Size by Type (2021-2026) 5 Endometriosis Therapies Breakdown Data by Application (2015-2026) 5.1 Global Endometriosis Therapies Market Size by Application (2015-2020) 5.2 Global Endometriosis Therapies Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Endometriosis Therapies Market Size (2015-2020) 6.2 Endometriosis Therapies Key Players in North America (2019-2020) 6.3 North America Endometriosis Therapies Market Size by Type (2015-2020) 6.4 North America Endometriosis Therapies Market Size by Application (2015-2020) 7 Europe 7.1 Europe Endometriosis Therapies Market Size (2015-2020) 7.2 Endometriosis Therapies Key Players in Europe (2019-2020) 7.3 Europe Endometriosis Therapies Market Size by Type (2015-2020) 7.4 Europe Endometriosis Therapies Market Size by Application (2015-2020) 8 China 8.1 China Endometriosis Therapies Market Size (2015-2020) 8.2 Endometriosis Therapies Key Players in China (2019-2020) 8.3 China Endometriosis Therapies Market Size by Type (2015-2020) 8.4 China Endometriosis Therapies Market Size by Application (2015-2020) 9 Japan 9.1 Japan Endometriosis Therapies Market Size (2015-2020) 9.2 Endometriosis Therapies Key Players in Japan (2019-2020) 9.3 Japan Endometriosis Therapies Market Size by Type (2015-2020) 9.4 Japan Endometriosis Therapies Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Endometriosis Therapies Market Size (2015-2020) 10.2 Endometriosis Therapies Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Endometriosis Therapies Market Size by Type (2015-2020) 10.4 Southeast Asia Endometriosis Therapies Market Size by Application (2015-2020) 11 India 11.1 India Endometriosis Therapies Market Size (2015-2020) 11.2 Endometriosis Therapies Key Players in India (2019-2020) 11.3 India Endometriosis Therapies Market Size by Type (2015-2020) 11.4 India Endometriosis Therapies Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Endometriosis Therapies Market Size (2015-2020) 12.2 Endometriosis Therapies Key Players in Central & South America (2019-2020) 12.3 Central & South America Endometriosis Therapies Market Size by Type (2015-2020) 12.4 Central & South America Endometriosis Therapies Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 AbbVie 13.1.1 AbbVie Company Details 13.1.2 AbbVie Business Overview and Its Total Revenue 13.1.3 AbbVie Endometriosis Therapies Introduction 13.1.4 AbbVie Revenue in Endometriosis Therapies Business (2015-2020)) 13.1.5 AbbVie Recent Development 13.2 Eli Lilly 13.2.1 Eli Lilly Company Details 13.2.2 Eli Lilly Business Overview and Its Total Revenue 13.2.3 Eli Lilly Endometriosis Therapies Introduction 13.2.4 Eli Lilly Revenue in Endometriosis Therapies Business (2015-2020) 13.2.5 Eli Lilly Recent Development 13.3 AstraZeneca 13.3.1 AstraZeneca Company Details 13.3.2 AstraZeneca Business Overview and Its Total Revenue 13.3.3 AstraZeneca Endometriosis Therapies Introduction 13.3.4 AstraZeneca Revenue in Endometriosis Therapies Business (2015-2020) 13.3.5 AstraZeneca Recent Development 13.4 Bayer 13.4.1 Bayer Company Details 13.4.2 Bayer Business Overview and Its Total Revenue 13.4.3 Bayer Endometriosis Therapies Introduction 13.4.4 Bayer Revenue in Endometriosis Therapies Business (2015-2020) 13.4.5 Bayer Recent Development 13.5 Astellas Pharma 13.5.1 Astellas Pharma Company Details 13.5.2 Astellas Pharma Business Overview and Its Total Revenue 13.5.3 Astellas Pharma Endometriosis Therapies Introduction 13.5.4 Astellas Pharma Revenue in Endometriosis Therapies Business (2015-2020) 13.5.5 Astellas Pharma Recent Development 13.6 Meditrina Pharmaceuticals 13.6.1 Meditrina Pharmaceuticals Company Details 13.6.2 Meditrina Pharmaceuticals Business Overview and Its Total Revenue 13.6.3 Meditrina Pharmaceuticals Endometriosis Therapies Introduction 13.6.4 Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2015-2020) 13.6.5 Meditrina Pharmaceuticals Recent Development 13.7 Pfizer 13.7.1 Pfizer Company Details 13.7.2 Pfizer Business Overview and Its Total Revenue 13.7.3 Pfizer Endometriosis Therapies Introduction 13.7.4 Pfizer Revenue in Endometriosis Therapies Business (2015-2020) 13.7.5 Pfizer Recent Development 13.8 Neurocrine Biosciences 13.8.1 Neurocrine Biosciences Company Details 13.8.2 Neurocrine Biosciences Business Overview and Its Total Revenue 13.8.3 Neurocrine Biosciences Endometriosis Therapies Introduction 13.8.4 Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2015-2020) 13.8.5 Neurocrine Biosciences Recent Development 13.9 Takeda Pharmaceutical 13.9.1 Takeda Pharmaceutical Company Details 13.9.2 Takeda Pharmaceutical Business Overview and Its Total Revenue 13.9.3 Takeda Pharmaceutical Endometriosis Therapies Introduction 13.9.4 Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2015-2020) 13.9.5 Takeda Pharmaceutical Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Endometriosis Therapies Key Market Segments Table 2. Key Players Covered: Ranking by Endometriosis Therapies Revenue Table 3. Ranking of Global Top Endometriosis Therapies Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Endometriosis Therapies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Hormonal Contraceptives Table 6. Key Players of Gonadotropin-releasingHormone(Gn-RH)Agonists Table 7. Key Players of Progestin Therapy Table 8. Key Players of Aromatase Inhibitors Table 9. Global Endometriosis Therapies Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 10. Global Endometriosis Therapies Market Size by Regions (US$ Million): 2020 VS 2026 Table 11. Global Endometriosis Therapies Market Size by Regions (2015-2020) (US$ Million) Table 12. Global Endometriosis Therapies Market Share by Regions (2015-2020) Table 13. Global Endometriosis Therapies Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 14. Global Endometriosis Therapies Market Share by Regions (2021-2026) Table 15. Market Top Trends Table 16. Key Drivers: Impact Analysis Table 17. Key Challenges Table 18. Endometriosis Therapies Market Growth Strategy Table 19. Main Points Interviewed from Key Endometriosis Therapies Players Table 20. Global Endometriosis Therapies Revenue by Players (2015-2020) (Million US$) Table 21. Global Endometriosis Therapies Market Share by Players (2015-2020) Table 22. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2019) Table 23. Global Endometriosis Therapies by Players Market Concentration Ratio (CR5 and HHI) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Endometriosis Therapies Product Solution and Service Table 26. Date of Enter into Endometriosis Therapies Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 29. Global Endometriosis Therapies Market Size Share by Type (2015-2020) Table 30. Global Endometriosis Therapies Revenue Market Share by Type (2021-2026) Table 31. Global Endometriosis Therapies Market Size Share by Application (2015-2020) Table 32. Global Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 33. Global Endometriosis Therapies Market Size Share by Application (2021-2026) Table 34. North America Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 35. North America Key Players Endometriosis Therapies Market Share (2019-2020) Table 36. North America Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 37. North America Endometriosis Therapies Market Share by Type (2015-2020) Table 38. North America Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 39. North America Endometriosis Therapies Market Share by Application (2015-2020) Table 40. Europe Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 41. Europe Key Players Endometriosis Therapies Market Share (2019-2020) Table 42. Europe Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 43. Europe Endometriosis Therapies Market Share by Type (2015-2020) Table 44. Europe Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 45. Europe Endometriosis Therapies Market Share by Application (2015-2020) Table 46. China Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 47. China Key Players Endometriosis Therapies Market Share (2019-2020) Table 48. China Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 49. China Endometriosis Therapies Market Share by Type (2015-2020) Table 50. China Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 51. China Endometriosis Therapies Market Share by Application (2015-2020) Table 52. Japan Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 53. Japan Key Players Endometriosis Therapies Market Share (2019-2020) Table 54. Japan Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 55. Japan Endometriosis Therapies Market Share by Type (2015-2020) Table 56. Japan Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 57. Japan Endometriosis Therapies Market Share by Application (2015-2020) Table 58. Southeast Asia Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 59. Southeast Asia Key Players Endometriosis Therapies Market Share (2019-2020) Table 60. Southeast Asia Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 61. Southeast Asia Endometriosis Therapies Market Share by Type (2015-2020) Table 62. Southeast Asia Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 63. Southeast Asia Endometriosis Therapies Market Share by Application (2015-2020) Table 64. India Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 65. India Key Players Endometriosis Therapies Market Share (2019-2020) Table 66. India Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 67. India Endometriosis Therapies Market Share by Type (2015-2020) Table 68. India Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 69. India Endometriosis Therapies Market Share by Application (2015-2020) Table 70. Central & South America Key Players Endometriosis Therapies Revenue (2019-2020) (Million US$) Table 71. Central & South America Key Players Endometriosis Therapies Market Share (2019-2020) Table 72. Central & South America Endometriosis Therapies Market Size by Type (2015-2020) (Million US$) Table 73. Central & South America Endometriosis Therapies Market Share by Type (2015-2020) Table 74. Central & South America Endometriosis Therapies Market Size by Application (2015-2020) (Million US$) Table 75. Central & South America Endometriosis Therapies Market Share by Application (2015-2020) Table 76. AbbVie Company Details Table 77. AbbVie Business Overview Table 78. AbbVie Product Table 79. AbbVie Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 80. AbbVie Recent Development Table 81. Eli Lilly Company Details Table 82. Eli Lilly Business Overview Table 83. Eli Lilly Product Table 84. Eli Lilly Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 85. Eli Lilly Recent Development Table 86. AstraZeneca Company Details Table 87. AstraZeneca Business Overview Table 88. AstraZeneca Product Table 89. AstraZeneca Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 90. AstraZeneca Recent Development Table 91. Bayer Company Details Table 92. Bayer Business Overview Table 93. Bayer Product Table 94. Bayer Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 95. Bayer Recent Development Table 96. Astellas Pharma Company Details Table 97. Astellas Pharma Business Overview Table 98. Astellas Pharma Product Table 99. Astellas Pharma Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 100. Astellas Pharma Recent Development Table 101. Meditrina Pharmaceuticals Company Details Table 102. Meditrina Pharmaceuticals Business Overview Table 103. Meditrina Pharmaceuticals Product Table 104. Meditrina Pharmaceuticals Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 105. Meditrina Pharmaceuticals Recent Development Table 106. Pfizer Company Details Table 107. Pfizer Business Overview Table 108. Pfizer Product Table 109. Pfizer Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 110. Pfizer Recent Development Table 111. Neurocrine Biosciences Business Overview Table 112. Neurocrine Biosciences Product Table 113. Neurocrine Biosciences Company Details Table 114. Neurocrine Biosciences Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 115. Neurocrine Biosciences Recent Development Table 116. Takeda Pharmaceutical Company Details Table 117. Takeda Pharmaceutical Business Overview Table 118. Takeda Pharmaceutical Product Table 119. Takeda Pharmaceutical Revenue in Endometriosis Therapies Business (2015-2020) (Million US$) Table 120. Takeda Pharmaceutical Recent Development Table 121. Research Programs/Design for This Report Table 122. Key Data Information from Secondary Sources Table 123. Key Data Information from Primary Sources List of Figures Figure 1. Global Endometriosis Therapies Market Share by Type: 2020 VS 2026 Figure 2. Hormonal Contraceptives Features Figure 3. Gonadotropin-releasingHormone(Gn-RH)Agonists Features Figure 4. Progestin Therapy Features Figure 5. Aromatase Inhibitors Features Figure 6. Global Endometriosis Therapies Market Share by Application: 2020 VS 2026 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Other Case Studies Figure 10. Endometriosis Therapies Report Years Considered Figure 11. Global Endometriosis Therapies Market Size YoY Growth 2015-2026 (US$ Million) Figure 12. Global Endometriosis Therapies Market Share by Regions: 2020 VS 2026 Figure 13. Global Endometriosis Therapies Market Share by Regions (2021-2026) Figure 14. Porter's Five Forces Analysis Figure 15. Global Endometriosis Therapies Market Share by Players in 2019 Figure 16. Global Top Endometriosis Therapies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Therapies as of 2019 Figure 17. The Top 10 and 5 Players Market Share by Endometriosis Therapies Revenue in 2019 Figure 18. North America Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Europe Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 20. China Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Japan Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Southeast Asia Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 23. India Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Central & South America Endometriosis Therapies Market Size YoY Growth (2015-2020) (Million US$) Figure 25. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 26. AbbVie Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 27. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 28. Eli Lilly Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 29. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 30. AstraZeneca Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 31. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 32. Bayer Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 33. Astellas Pharma Total Revenue (US$ Million): 2019 Compared with 2018 Figure 34. Astellas Pharma Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 35. Meditrina Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 36. Meditrina Pharmaceuticals Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 37. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 38. Pfizer Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 39. Neurocrine Biosciences Total Revenue (US$ Million): 2019 Compared with 2018 Figure 40. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 41. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 42. Takeda Pharmaceutical Revenue Growth Rate in Endometriosis Therapies Business (2015-2020) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

AbbVie Eli Lilly AstraZeneca Bayer Astellas Pharma Meditrina Pharmaceuticals Pfizer Neurocrine Biosciences Takeda Pharmaceutical